Texas A&M University researchers are pioneering organ-on-a-chip (OoC) technology to revolutionize chemical safety testing, potentially eliminating the need for animal testing. Led by Dr. Arum Han, a professor and associate dean for research in electrical and computer engineering, this initiative is part of a $15.3 million National Institutes of Health (NIH)-funded center dedicated to advancing New Approach Methodologies (NAMs) for toxicology.
Organ-on-a-chip devices are sophisticated microfluidic platforms lined with living human cells that emulate the functioning of real organs. These tiny, USB-sized chips can mimic complex biological processes such as lung respiration or blood flow within vessels. By growing human tissue samples—including gut, skin, and brain cells—on these chips, researchers can observe organ-level responses to chemicals in real time, offering substantial improvements over conventional animal models.
Historically, chemical safety assessments have depended heavily on animal subjects, a method criticized for ethical concerns, high costs, and slow turnaround times. OoC technology addresses these issues by providing a human-relevant platform that accelerates the toxicity screening process while reducing expenses. This is particularly crucial as regulatory agencies and industries face increasing pressure to replace animal testing, especially in regions with strict bans on animal use, like in cosmetic product evaluation.
Dr. Han’s team is uniquely focused on chemical toxicity rather than drug safety, leveraging Texas A&M’s renowned toxicology expertise. The lab aims to develop chip systems capable of high-throughput testing that not only detect toxicity but also elucidate the underlying biological mechanisms of harm. Understanding these mechanisms allows for the identification of safer chemical alternatives early in development.
Beyond early screening, these organ chips serve as powerful investigative tools for environmental health researchers, toxicologists, regulators, and manufacturers. By flagging hazardous substances before they reach costly animal experiments or human trials, OoCs streamline the path from discovery to regulatory approval, ultimately enhancing public health protection.
While many laboratories explore organ-on-a-chip models for pharmaceutical purposes, the Texas A&M initiative emphasizes broadening the technology’s application to diverse chemicals, improving predictive accuracy and throughput capacity. The team envisions a future where comprehensive data from these chips will satisfy regulatory demands, reducing reliance on animal models while providing more biologically relevant insights.
Supported by the NIH’s Complement-ARIE program, this research marks a paradigm shift in toxicology testing. It offers a compelling vision of safety evaluation that is faster, more ethical, and better aligned with human biology. As organ-on-a-chip systems evolve, they promise to reshape how science approaches toxicity, fostering innovation and ethical responsibility simultaneously.
Image Credits: Dr. Arum Han
Subject of Research: Organ-on-a-chip technology for chemical toxicity testing
Article Title: Texas A&M Advances Organ-on-a-Chip Systems to Replace Animal Testing in Chemical Safety
News Publication Date: Not provided
Web References: https://engineering.tamu.edu/electrical/profiles/ahan.html; https://www.nih.gov/news-events/news-releases/nih-invests-150-million-human-based-research-reduce-use-animal-models
Tags: advancements in human-recost-effective toxicity testing methodsdevelopment of New Approach Methodologies (NAMs)ethical alternatives to animal testinghuman tissue-based chemical safety assessmentmicrofluidic platforms for toxicology testingmicrophysiological systems for drug testingNIH-funded organ-on-chip researchorgan-on-a-chip for lung and blood flow modelingorgan-on-a-chip technologyreal-time organ response to chemicalsregulatory impact of organ-on-a-chip technologyTexas A&M University organ-on-chip innovations
